Hikma Pharmaceuticals Plc Director Declaration
29 Julho 2024 - 12:08PM
RNS Regulatory News
RNS Number : 2662Y
Hikma Pharmaceuticals Plc
29 July 2024
Hikma Pharmaceuticals
PLC
Director
Declaration
LONDON, 29 July 2024: Pursuant to
Listing Rule 9.6.14, Hikma Pharmaceuticals PLC confirms that
Victoria Hull, Senior Independent Non-Executive Director, has been
appointed as a Non-Executive Director of IMI plc with effect from 1
August 2024.
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
|
|
Helen Middlemist
Group Company Secretary
|
+44 20
7399 2760
|
Hikma Pharmaceuticals PLC (LSE: HIK)
(NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI:
549300BNS685UXH4JI75)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RDNRLMATMTMTBRI
Hikma Pharmaceuticals (LSE:HIK)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Hikma Pharmaceuticals (LSE:HIK)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024